Clinical Trial Update: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

ASLAN Pharmaceuticals reports that the Phase 2b trial of ASLAN004 for adults with moderate-to-severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ASLAN004

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED